1.
Jonathan Weiss, Martin Peifer, Carmen D. Herling, Lukas P. Frenzel, Michael Hallek. Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (Comment to Tausch et al.). haematol [Internet]. 2019Nov.1 [cited 2021Jan.24];104(11):e540-e540. Available from: https://haematologica.org/article/view/9149